Loading...

AtriCure, Inc.

ATRCNASDAQ
Healthcare
Medical - Instruments & Supplies
$31.50
$1.33(4.41%)

AtriCure, Inc. (ATRC) Stock Overview

Explore AtriCure, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 71.4/100

Key Financials

Market Cap1.6B
P/E Ratio-38.86
EPS (TTM)$-0.81
ROE-0.08%
Fundamental Analysis

AI Price Forecasts

1 Week$35.71
1 Month$36.21
3 Months$38.71
1 Year Target$23.62

ATRC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AtriCure, Inc. (ATRC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.24, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $23.62.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -38.86 and a market capitalization of 1.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;